OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways
Jianwei Qu, Yifan Hou, Qingxiao Chen, et al.
Oncogene (2021) Vol. 41, Iss. 3, pp. 400-413
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5
Zhen Fang, Bo Mu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114446-114446
Closed Access | Times Cited: 39

N6‐methyladenosine (m6A) modification in gynecological malignancies
Chunmei Zhang, Ning Liu
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3465-3479
Closed Access | Times Cited: 30

Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8

RNA m6Amethylation in cancer
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 28

Novel insights into the interplay between m6A modification and programmed cell death in cancer
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 6, pp. 1748-1763
Open Access | Times Cited: 16

Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5

ALKBH5 regulates chicken adipogenesis by mediating LCAT mRNA stability depending on m6A modification
Xiaohuan Chao, Lijin Guo, Chutian Ye, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4

Discovery of a Novel Selective and Cell-Active N6-Methyladenosine RNA Demethylase ALKBH5 Inhibitor
Xianyuan Yang, K. X. Huang, Xu-Nian Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Orchestration of immunoregulatory signaling ligand and receptor dynamics by mRNA modifications: Implications for therapeutic potential
Zizhao Mai, Xu Chen, Ye Lu, et al.
International Journal of Biological Macromolecules (2025), pp. 142987-142987
Closed Access

RNA demethylase ALKBH5 regulates cell cycle progression in DNA damage response
Bo Gao, Hai‐Tao Pan, Xiaoling Zhou, et al.
Research Square (Research Square) (2025)
Closed Access

ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators
Zhonglin Cai, Huan Xu, Gang Bai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17

Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer
Hao Su, Henley Cheung, Harry Cheuk-Hay Lau, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 4
Closed Access | Times Cited: 10

Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases
Juanjuan Han, C Wang, Haolin Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 514-514
Open Access | Times Cited: 3

Effect of Bortezomib Treatment in Multiple Myeloma on Blood Coagulation Function, Renal Function, Immune Function, and the NF-κB Pathway-Associated Indicators
Jian Tao, Ling Wang, Zheyun Gu, et al.
British Journal of Hospital Medicine (2025) Vol. 86, Iss. 3, pp. 1-15
Closed Access

Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma
Xiaoqi Sun, Yongming Zhou, Wenwei Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications
Lusheng Liu, David H. Ge, Yumeng Lin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

From bone marrow mesenchymal stem cells to diseases: the crucial role of m6A methylation in orthopedics
Jing Li, Chu Zhang, Wen Yin, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access

RNA demethylase ALKBH5 regulates cell cycle progression in DNA damage response
Bo Gao, Hai‐Tao Pan, Xiaoling Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies
Yan Zhao, Hongling Peng
Cancers (2022) Vol. 14, Iss. 2, pp. 332-332
Open Access | Times Cited: 15

Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing
Yinghui Hong, Jun Li, Yinsheng Zhong, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107601-107601
Open Access | Times Cited: 8

IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner
Jiadai Xu, Yawen Wang, Liang Ren, et al.
Genes & Diseases (2024) Vol. 12, Iss. 1, pp. 101214-101214
Open Access | Times Cited: 2

Enhanced Precision Therapy of Multiple Myeloma Through Engineered Biomimetic Nanoparticles with Dual Targeting
Ruogu Qi, Shanshan Wang, Jiayi Yu, et al.
Engineering (2024) Vol. 36, pp. 178-192
Open Access | Times Cited: 2

The methyltransferase METTL3 regulates endothelial cell proliferation and inflammation via m6A RNA methylation-mediated TRAF1 expression
Du-Chu Chen, Wentao Xu, Huaxian Zheng, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 732, pp. 150399-150399
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top